Funding Received
$26.7 Million in 1 Round from 9 Investors
Most Recent Funding
$26.7 Million Series C on November 24, 2009
Headquarters:
Abingdon
Description:
Oxagen is a biopharmaceutical company developing small molecule drugs addressing asthma, and chronic allergic and inflammatory conditions.
Founders:
John Bell
Categories:
Biotechnology
Website:
http://www.oxagen.co.uk

Company Details

Update

Oxagen Limited, a biopharmaceutical company, provides drug discovery and development solutions. It offers molecule drugs for the treatment of asthma, autoimmune disease, inflammatory bowel, psoriasis, allergy, and rheumatoid arthritis diseases. Oxagen Limited was founded in 1997 and is based in Abingdon, the United Kingdom.

Current Team (4)

Update

Past Team (2)

Update

Board Members and Advisors (1)

Update

Investors (9)

Update

Offices/Locations (1)

Update
  • Office

    91 Milton Park

    Abingdon, OX14 4RY

    GBR

Images (1)

Update
  • A79e938e0fc31bf13abf111636a85313